Apellis Pharmaceuticals Other Long Term Assets (Quarterly) Analysis

Apellis Pharmaceuticals, Inc. (APLS)

22.02 +1.07 (+5.11%) USD | NASDAQ | Jan 22, 16:00

22.05 +0.03 (+0.14%) After-Hours: 18:49

View Other Long Term Assets (Quarterly) for APLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Ionis Pharmaceuticals, Inc.	Upgrade
Fortress Biotech, Inc.	Upgrade
Sarepta Therapeutics, Inc.	Upgrade